APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Invasive Cancer Detection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Non-Invasive Cancer Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

5 June 2026187 pages

Choose your research edition.

Industry ResearchNon-Invasive Cancer Detection Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Invasive Cancer Detection Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Non-Invasive Cancer Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Invasive Cancer Detection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Invasive Cancer Detection Market Analysis and Forecast 2026-2032241 pages · $4,950 USD

Market perspective

The global Non-Invasive Cancer Detection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Non-Invasive Cancer Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-Invasive Cancer Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Invasive Cancer Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Non-Invasive Cancer Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-Invasive Cancer Detection include Trublood, Datar Cancer Genetics, Nucleix, miR Scientific, Owlstone Medical, bioAffinity Technologies, Nonacus and Amadix, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Non-Invasive Cancer Detection market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-Invasive Cancer Detection and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-Invasive Cancer Detection revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Non-Invasive Cancer Detection market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-Invasive Cancer Detection Segment by Company

Trublood

Datar Cancer Genetics

Nucleix

miR Scientific

Owlstone Medical

bioAffinity Technologies

Nonacus

Amadix

Non-Invasive Cancer Detection Segment by Type

Imaging Test

Nuclear Medicine Test

Others

Non-Invasive Cancer Detection Segment by Application

Prostate Cancer

Bladder Cancer

Pancreatic Cancer

Breast Cancer

Gastric Cancer

Others

Non-Invasive Cancer Detection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Invasive Cancer Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Invasive Cancer Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Invasive Cancer Detection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Non-Invasive Cancer Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-Invasive Cancer Detection industry.

Chapter 3: Detailed analysis of Non-Invasive Cancer Detection companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-Invasive Cancer Detectionrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-Invasive Cancer Detection Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Imaging Test Table 3. Key Players of Nuclear Medicine Test Table 4. Key Players of Others Table 4. Global Non-Invasive Cancer Detection Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Prostate Cancer Table 6. Key Players of Bladder Cancer Table 7. Key Players of Pancreatic Cancer Table 8. Key Players of Breast Cancer Table 9. Key Players of Gastric Cancer Table 10. Key Players of Others Table 11. Global Non-Invasive Cancer Detection Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Non-Invasive Cancer Detection Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Non-Invasive Cancer Detection Market Share by Region (2021-2026) Table 14. Global Non-Invasive Cancer Detection Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Non-Invasive Cancer Detection Market Share by Region (2027-2032) Table 16. Non-Invasive Cancer Detection Industry Trends Table 17. Non-Invasive Cancer Detection Industry Drivers Table 18. Non-Invasive Cancer Detection Industry Opportunities and Challenges Table 19. Non-Invasive Cancer Detection Industry Restraints Table 20. Global Non-Invasive Cancer Detection Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Non-Invasive Cancer Detection Revenue Market Share by Company (2021-2026) Table 22. Global Non-Invasive Cancer Detection Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Non-Invasive Cancer Detection Key Company Head Office and Area Served Table 24. Global Non-Invasive Cancer Detection Company, Product Type & Application Table 25. Global Non-Invasive Cancer Detection Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Non-Invasive Cancer Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Non-Invasive Cancer Detection Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Non-Invasive Cancer Detection Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Non-Invasive Cancer Detection Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Non-Invasive Cancer Detection Revenue Market Share by Type (2021-2026) Table 32. Global Non-Invasive Cancer Detection Revenue Market Share by Type (2027-2032) Table 33. Global Non-Invasive Cancer Detection Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Non-Invasive Cancer Detection Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Non-Invasive Cancer Detection Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Non-Invasive Cancer Detection Revenue Market Share by Application (2021-2026) Table 37. Global Non-Invasive Cancer Detection Revenue Market Share by Application (2027-2032) Table 38. Trublood Company Information Table 39. Trublood Business Overview Table 40. Trublood Non-Invasive Cancer Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Trublood Non-Invasive Cancer Detection Product Portfolio Table 42. Trublood Recent Development Table 43. Datar Cancer Genetics Company Information Table 44. Datar Cancer Genetics Business Overview Table 45. Datar Cancer Genetics Non-Invasive Cancer Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Datar Cancer Genetics Non-Invasive Cancer Detection Product Portfolio Table 47. Datar Cancer Genetics Recent Development Table 48. Nucleix Company Information Table 49. Nucleix Business Overview Table 50. Nucleix Non-Invasive Cancer Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Nucleix Non-Invasive Cancer Detection Product Portfolio Table 52. Nucleix Recent Development Table 53. miR Scientific Company Information Table 54. miR Scientific Business Overview Table 55. miR Scientific Non-Invasive Cancer Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. miR Scientific Non-Invasive Cancer Detection Product Portfolio Table 57. miR Scientific Recent Development Table 58. Owlstone Medical Company Information Table 59. Owlstone Medical Business Overview Table 60. Owlstone Medical Non-Invasive Cancer Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Owlstone Medical Non-Invasive Cancer Detection Product Portfolio Table 62. Owlstone Medical Recent Development Table 63. bioAffinity Technologies Company Information Table 64. bioAffinity Technologies Business Overview Table 65. bioAffinity Technologies Non-Invasive Cancer Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. bioAffinity Technologies Non-Invasive Cancer Detection Product Portfolio Table 67. bioAffinity Technologies Recent Development Table 68. Nonacus Company Information Table 69. Nonacus Business Overview Table 70. Nonacus Non-Invasive Cancer Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Nonacus Non-Invasive Cancer Detection Product Portfolio Table 72. Nonacus Recent Development Table 73. Amadix Company Information Table 74. Amadix Business Overview Table 75. Amadix Non-Invasive Cancer Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Amadix Non-Invasive Cancer Detection Product Portfolio Table 77. Amadix Recent Development Table 78. North America Non-Invasive Cancer Detection Market Size by Type (2021-2026) & (US$ Million) Table 79. North America Non-Invasive Cancer Detection Market Size by Type (2027-2032) & (US$ Million) Table 80. North America Non-Invasive Cancer Detection Market Size by Application (2021-2026) & (US$ Million) Table 81. North America Non-Invasive Cancer Detection Market Size by Application (2027-2032) & (US$ Million) Table 82. North America Non-Invasive Cancer Detection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 83. North America Non-Invasive Cancer Detection Market Size by Country (2021-2026) Table 84. North America Non-Invasive Cancer Detection Market Size by Country (2027-2032) Table 85. Europe Non-Invasive Cancer Detection Market Size by Type (2021-2026) & (US$ Million) Table 86. Europe Non-Invasive Cancer Detection Market Size by Type (2027-2032) & (US$ Million) Table 87. Europe Non-Invasive Cancer Detection Market Size by Application (2021-2026) & (US$ Million) Table 88. Europe Non-Invasive Cancer Detection Market Size by Application (2027-2032) & (US$ Million) Table 89. Europe Non-Invasive Cancer Detection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. Europe Non-Invasive Cancer Detection Market Size by Country (2021-2026) Table 91. Europe Non-Invasive Cancer Detection Market Size by Country (2027-2032) Table 92. China Non-Invasive Cancer Detection Market Size by Type (2021-2026) & (US$ Million) Table 93. China Non-Invasive Cancer Detection Market Size by Type (2027-2032) & (US$ Million) Table 94. China Non-Invasive Cancer Detection Market Size by Application (2021-2026) & (US$ Million) Table 95. China Non-Invasive Cancer Detection Market Size by Application (2027-2032) & (US$ Million) Table 96. Asia Non-Invasive Cancer Detection Market Size by Type (2021-2026) & (US$ Million) Table 97. Asia Non-Invasive Cancer Detection Market Size by Type (2027-2032) & (US$ Million) Table 98. Asia Non-Invasive Cancer Detection Market Size by Application (2021-2026) & (US$ Million) Table 99. Asia Non-Invasive Cancer Detection Market Size by Application (2027-2032) & (US$ Million) Table 100. Asia Non-Invasive Cancer Detection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Asia Non-Invasive Cancer Detection Market Size by Country (2021-2026) Table 102. Asia Non-Invasive Cancer Detection Market Size by Country (2027-2032) Table 103. South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Type (2021-2026) & (US$ Million) Table 104. South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Type (2027-2032) & (US$ Million) Table 105. South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Application (2021-2026) & (US$ Million) Table 106. South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Application (2027-2032) & (US$ Million) Table 107. South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Country (2021-2026) Table 109. South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Country (2027-2032) Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Non-Invasive Cancer Detection Product Image Figure 2. Global Non-Invasive Cancer Detection Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Non-Invasive Cancer Detection Market Share by Type: 2025 VS 2032 Figure 4. Imaging Test Image Figure 5. Nuclear Medicine Test Image Figure 6. Others Image Figure 7. Global Non-Invasive Cancer Detection Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Non-Invasive Cancer Detection Market Share by Application: 2025 VS 2032 Figure 9. Prostate Cancer Image Figure 10. Bladder Cancer Image Figure 11. Pancreatic Cancer Image Figure 12. Breast Cancer Image Figure 13. Gastric Cancer Image Figure 14. Others Image Figure 15. Global Non-Invasive Cancer Detection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 17. Global Non-Invasive Cancer Detection Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Non-Invasive Cancer Detection Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Non-Invasive Cancer Detection Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Non-Invasive Cancer Detection Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Non-Invasive Cancer Detection Revenue Market Share by Type (2021-2032) Figure 24. Global Non-Invasive Cancer Detection Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Non-Invasive Cancer Detection Revenue Market Share by Application (2021-2032) Figure 26. North America Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 27. North America Non-Invasive Cancer Detection Market Share by Type (2021-2032) Figure 28. North America Non-Invasive Cancer Detection Market Share by Application (2021-2032) Figure 29. North America Non-Invasive Cancer Detection Market Share by Country (2021-2032) Figure 30. United States Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 31. Canada Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 33. Europe Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 34. Europe Non-Invasive Cancer Detection Market Share by Type (2021-2032) Figure 35. Europe Non-Invasive Cancer Detection Market Share by Application (2021-2032) Figure 36. Europe Non-Invasive Cancer Detection Market Share by Country (2021-2032) Figure 37. Germany Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 38. France Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 40. Italy Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 41. Russia Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 43. China Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 44. China Non-Invasive Cancer Detection Market Share by Type (2021-2032) Figure 45. China Non-Invasive Cancer Detection Market Share by Application (2021-2032) Figure 46. Asia Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 47. Asia Non-Invasive Cancer Detection Market Share by Type (2021-2032) Figure 48. Asia Non-Invasive Cancer Detection Market Share by Application (2021-2032) Figure 49. Asia Non-Invasive Cancer Detection Market Share by Country (2021-2032) Figure 50. Japan Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 54. India Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 55. Australia Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Non-Invasive Cancer Detection Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Non-Invasive Cancer Detection Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Non-Invasive Cancer Detection Market Share by Country (2021-2032) Figure 60. Brazil Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 65. UAE Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 67. Chile Non-Invasive Cancer Detection Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Imaging Test
  • Nuclear Medicine Test
  • Others
Applications
  • Prostate Cancer
  • Bladder Cancer
  • Pancreatic Cancer
  • Breast Cancer
  • Gastric Cancer
  • Others
Companies covered
  • Trublood
  • Datar Cancer Genetics
  • Nucleix
  • miR Scientific
  • Owlstone Medical
  • bioAffinity Technologies
  • Nonacus
  • Amadix

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Non-Invasive Cancer Detection Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Imaging Test
  5. 1.2.3 Nuclear Medicine Test
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Non-Invasive Cancer Detection Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Prostate Cancer
  10. 1.3.3 Bladder Cancer
  11. 1.3.4 Pancreatic Cancer
  12. 1.3.5 Breast Cancer
  13. 1.3.6 Gastric Cancer
  14. 1.3.7 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Non-Invasive Cancer Detection Growth Trends by Region
  17. 1.5.1 Global Non-Invasive Cancer Detection Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Non-Invasive Cancer Detection Market Size by Region (2021-2026)
  19. 1.5.3 Non-Invasive Cancer Detection Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Non-Invasive Cancer Detection Market Dynamics
  1. 2.1 Non-Invasive Cancer Detection Industry Trends
  2. 2.2 Non-Invasive Cancer Detection Industry Drivers
  3. 2.3 Non-Invasive Cancer Detection Industry Opportunities and Challenges
  4. 2.4 Non-Invasive Cancer Detection Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Non-Invasive Cancer Detection Revenue by Company (2021-2026)
  2. 3.2 Global Non-Invasive Cancer Detection Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Non-Invasive Cancer Detection Key Company Head office and Area Served
  4. 3.4 Global Non-Invasive Cancer Detection Company, Product Type & Application
  5. 3.5 Global Non-Invasive Cancer Detection Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Non-Invasive Cancer Detection Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Non-Invasive Cancer Detection Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Non-Invasive Cancer Detection Tier 1, Tier 2, and Tier 3
4 Non-Invasive Cancer Detection Market by Type
  1. 4.1 Global Non-Invasive Cancer Detection Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Non-Invasive Cancer Detection Market Size by Type (2021-2032)
  3. 4.3 Global Non-Invasive Cancer Detection Market Size Share by Type (2021-2032)
5 Non-Invasive Cancer Detection Market by Application
  1. 5.1 Global Non-Invasive Cancer Detection Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Non-Invasive Cancer Detection Market Size by Application (2021-2032)
  3. 5.3 Global Non-Invasive Cancer Detection Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Trublood
  2. 6.1.1 Trublood Company Information
  3. 6.1.2 Trublood Business Overview
  4. 6.1.3 Trublood Non-Invasive Cancer Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Trublood Non-Invasive Cancer Detection Product Portfolio
  6. 6.1.5 Trublood Recent Developments
  7. 6.2 Datar Cancer Genetics
  8. 6.2.1 Datar Cancer Genetics Company Information
  9. 6.2.2 Datar Cancer Genetics Business Overview
  10. 6.2.3 Datar Cancer Genetics Non-Invasive Cancer Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Datar Cancer Genetics Non-Invasive Cancer Detection Product Portfolio
  12. 6.2.5 Datar Cancer Genetics Recent Developments
  13. 6.3 Nucleix
  14. 6.3.1 Nucleix Company Information
  15. 6.3.2 Nucleix Business Overview
  16. 6.3.3 Nucleix Non-Invasive Cancer Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Nucleix Non-Invasive Cancer Detection Product Portfolio
  18. 6.3.5 Nucleix Recent Developments
  19. 6.4 miR Scientific
  20. 6.4.1 miR Scientific Company Information
  21. 6.4.2 miR Scientific Business Overview
  22. 6.4.3 miR Scientific Non-Invasive Cancer Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 miR Scientific Non-Invasive Cancer Detection Product Portfolio
  24. 6.4.5 miR Scientific Recent Developments
  25. 6.5 Owlstone Medical
  26. 6.5.1 Owlstone Medical Company Information
  27. 6.5.2 Owlstone Medical Business Overview
  28. 6.5.3 Owlstone Medical Non-Invasive Cancer Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Owlstone Medical Non-Invasive Cancer Detection Product Portfolio
  30. 6.5.5 Owlstone Medical Recent Developments
  31. 6.6 bioAffinity Technologies
  32. 6.6.1 bioAffinity Technologies Company Information
  33. 6.6.2 bioAffinity Technologies Business Overview
  34. 6.6.3 bioAffinity Technologies Non-Invasive Cancer Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 bioAffinity Technologies Non-Invasive Cancer Detection Product Portfolio
  36. 6.6.5 bioAffinity Technologies Recent Developments
  37. 6.7 Nonacus
  38. 6.7.1 Nonacus Company Information
  39. 6.7.2 Nonacus Business Overview
  40. 6.7.3 Nonacus Non-Invasive Cancer Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Nonacus Non-Invasive Cancer Detection Product Portfolio
  42. 6.7.5 Nonacus Recent Developments
  43. 6.8 Amadix
  44. 6.8.1 Amadix Company Information
  45. 6.8.2 Amadix Business Overview
  46. 6.8.3 Amadix Non-Invasive Cancer Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Amadix Non-Invasive Cancer Detection Product Portfolio
  48. 6.8.5 Amadix Recent Developments
7 North America
  1. 7.1 North America Non-Invasive Cancer Detection Market Size (2021-2032)
  2. 7.2 North America Non-Invasive Cancer Detection Market Size by Type
  3. 7.2.1 North America Non-Invasive Cancer Detection Market Size by Type (2021-2026)
  4. 7.2.2 North America Non-Invasive Cancer Detection Market Size by Type (2027-2032)
  5. 7.2.3 North America Non-Invasive Cancer Detection Market Share by Type (2021-2032)
  6. 7.3 North America Non-Invasive Cancer Detection Market Size by Application
  7. 7.3.1 North America Non-Invasive Cancer Detection Market Size by Application (2021-2026)
  8. 7.3.2 North America Non-Invasive Cancer Detection Market Size by Application (2027-2032)
  9. 7.3.3 North America Non-Invasive Cancer Detection Market Share by Application (2021-2032)
  10. 7.4 North America Non-Invasive Cancer Detection Market Size by Country
  11. 7.4.1 North America Non-Invasive Cancer Detection Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Non-Invasive Cancer Detection Market Size by Country (2021-2026)
  13. 7.4.3 North America Non-Invasive Cancer Detection Market Size by Country (2027-2032)
  14. 7.4.4 North America Non-Invasive Cancer Detection Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Non-Invasive Cancer Detection Market Size (2021-2032)
  2. 8.2 Europe Non-Invasive Cancer Detection Market Size by Type
  3. 8.2.1 Europe Non-Invasive Cancer Detection Market Size by Type (2021-2026)
  4. 8.2.2 Europe Non-Invasive Cancer Detection Market Size by Type (2027-2032)
  5. 8.2.3 Europe Non-Invasive Cancer Detection Market Share by Type (2021-2032)
  6. 8.3 Europe Non-Invasive Cancer Detection Market Size by Application
  7. 8.3.1 Europe Non-Invasive Cancer Detection Market Size by Application (2021-2026)
  8. 8.3.2 Europe Non-Invasive Cancer Detection Market Size by Application (2027-2032)
  9. 8.3.3 Europe Non-Invasive Cancer Detection Market Share by Application (2021-2032)
  10. 8.4 Europe Non-Invasive Cancer Detection Market Size by Country
  11. 8.4.1 Europe Non-Invasive Cancer Detection Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Non-Invasive Cancer Detection Market Size by Country (2021-2026)
  13. 8.4.3 Europe Non-Invasive Cancer Detection Market Size by Country (2027-2032)
  14. 8.4.4 Europe Non-Invasive Cancer Detection Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Non-Invasive Cancer Detection Market Size (2021-2032)
  2. 9.2 China Non-Invasive Cancer Detection Market Size by Type
  3. 9.2.1 China Non-Invasive Cancer Detection Market Size by Type (2021-2026)
  4. 9.2.2 China Non-Invasive Cancer Detection Market Size by Type (2027-2032)
  5. 9.2.3 China Non-Invasive Cancer Detection Market Share by Type (2021-2032)
  6. 9.3 China Non-Invasive Cancer Detection Market Size by Application
  7. 9.3.1 China Non-Invasive Cancer Detection Market Size by Application (2021-2026)
  8. 9.3.2 China Non-Invasive Cancer Detection Market Size by Application (2027-2032)
  9. 9.3.3 China Non-Invasive Cancer Detection Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Non-Invasive Cancer Detection Market Size (2021-2032)
  2. 10.2 Asia Non-Invasive Cancer Detection Market Size by Type
  3. 10.2.1 Asia Non-Invasive Cancer Detection Market Size by Type (2021-2026)
  4. 10.2.2 Asia Non-Invasive Cancer Detection Market Size by Type (2027-2032)
  5. 10.2.3 Asia Non-Invasive Cancer Detection Market Share by Type (2021-2032)
  6. 10.3 Asia Non-Invasive Cancer Detection Market Size by Application
  7. 10.3.1 Asia Non-Invasive Cancer Detection Market Size by Application (2021-2026)
  8. 10.3.2 Asia Non-Invasive Cancer Detection Market Size by Application (2027-2032)
  9. 10.3.3 Asia Non-Invasive Cancer Detection Market Share by Application (2021-2032)
  10. 10.4 Asia Non-Invasive Cancer Detection Market Size by Country
  11. 10.4.1 Asia Non-Invasive Cancer Detection Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Non-Invasive Cancer Detection Market Size by Country (2021-2026)
  13. 10.4.3 Asia Non-Invasive Cancer Detection Market Size by Country (2027-2032)
  14. 10.4.4 Asia Non-Invasive Cancer Detection Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Non-Invasive Cancer Detection Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Non-Invasive Cancer Detection Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Non-Invasive Cancer Detection Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Non-Invasive Cancer Detection Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Non-Invasive Cancer Detection Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst